2NAO | pdb_00002nao

Atomic resolution structure of a disease-relevant Abeta(1-42) amyloid fibril

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	DARR	100 mM sodium chloride, 100 mM sodium phosphate, 100 uM zinc chloride	95% H2O/5% D2O		7.4	ambient	277
2	PAR	100 mM sodium chloride, 100 mM sodium phosphate, 100 uM zinc chloride	95% H2O/5% D2O		7.4	ambient	277
3	PAIN	100 mM sodium chloride, 100 mM sodium phosphate, 100 uM zinc chloride	95% H2O/5% D2O		7.4	ambient	277
4	CHHC	100 mM sodium chloride, 100 mM sodium phosphate, 100 uM zinc chloride	95% H2O/5% D2O		7.4	ambient	277
5	NHHC	100 mM sodium chloride, 100 mM sodium phosphate, 100 uM zinc chloride	95% H2O/5% D2O		7.4	ambient	277
6	TEDOR	100 mM sodium chloride, 100 mM sodium phosphate, 100 uM zinc chloride	95% H2O/5% D2O		7.4	ambient	277

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	850

NMR Refinement
Method	Details	Software
torsion angle dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	500
Conformers Submitted Total Number	10
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA	3.97	Guntert
2	refinement	CYANA	3.97	Guntert

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.